Nurix (NRIX) Stock Price Target Raised to $34 by H.C. Wainwright
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has raised its price target for Nurix Therapeutics (NRIX) to $34 per share. This revised target reflects an optimistic view on the company's potential growth and market opportunities. Nurix's stock may react positively as analysts adjust expectations based on recent developments. Investors should note that analysts' price targets can influence trading behavior and market sentiment.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
